UPDATE: Standpoint Research Initiates NutriSystem at Buy
Standpoint Research initiates its coverage on NutriSystem (NASDAQ: NTRI) with a Buy rating and a target price of $16 on
Standpoint Research says, " Management of the company is currently exploring a sustainable retail business that will complement the direct selling business of the company and will also help to expand the company's reach and strengthen its brand. NTRI will be able to leverage the direct businesses marketing halo and also the supply chain infrastructure to serve retail customers directly. NTRI's well-positioned brand will allow it to carve out a nice spot for itself in the retail market."
NTRI closed at 11.20 a share on Friday.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.